Skip to main content
. 2020 Nov 25;21:974. doi: 10.1186/s13063-020-04897-9

Table 3.

Timeline for study participants

Schedule of events
Day 0 visit Day 7 visit (+/− 2 days) Unscheduled visit
Informed consent and enrolment x
Demographic data collection x
History/physical examination x x x
Diagnostic tests x
Treatment prescription x x
Patient adherence evaluation x x
Collection of qualitative data x x
Delivery of communication messages x
Adverse event monitoring (see Safety reporting section) x x